US Stock MarketDetailed Quotes
LUCD Lucid Diagnostics
- 1.040
- +0.040+4.00%
Close Nov 8 16:00 ET
- 1.000
- -0.040-3.85%
Post 19:54 ET
56.15MMarket Cap-859P/E (TTM)
1.040High0.980Low433.17KVolume1.000Open1.000Pre Close436.29KTurnover2.29%Turnover RatioLossP/E (Static)53.99MShares1.58052wk High-1.41P/B19.69MFloat Cap0.63052wk Low--Dividend TTM18.93MShs Float13.520Historical High--Div YieldTTM6.00%Amplitude0.630Historical Low1.007Avg Price1Lot Size
About Lucid Diagnostics Company
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
Company Profile
SymbolLUCD
Company NameLucid Diagnostics
Listing DateOct 14, 2021
Issue Price14.00
Founded2018
CEODr. Lishan Aklog, M.D.
MarketNASDAQ
Employees70
Fiscal Year Ends12-31
Address360 Madison Avenue,25th Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-212-949-4319
Websitehttp://www.luciddx.com
Company Executives
- Name
- Position
- Salary
- Dr. Lishan Aklog, M.D.
- Chief Executive Officer and Chairman of the Board
- 300.00K
- Dennis M. McGrath, C.P.A.
- Principal Accounting Officer and Chief Financial Officer
- 225.00K
- Shaun M. O'Neil
- President and Chief Operating Officer
- 162.50K
- Stanley N. Lapidus
- Vice Chairman of the Board
- 214.75K
- Dennis Matheis
- Director
- --
- Ronald M. Sparks, Jr
- Independent Director
- 262.25K
- Dr. Jacque J. Sokolov,M.D.
- Independent Director
- 252.25K
- Debra J. White
- Independent Director
- 232.25K
- Dr. James L. Cox, M.D.
- Independent Director
- 227.75K
- Michael Adam Gordon
- General Counsel and Secretary
- 250.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data